semaglutide with adderall What's behind shortages of Adderall, Ozempic and other meds? What You Need to Know

The enforcement scale is real: more than 455 FDA adverse-event reports tied to compounded semaglutide, over 50 warning letters to compounded GLP-1 sellers in 2025, and 30-plus more in March 2026, several of them naming the compounding pharmacies behind telehealth brands

If you want a clear next step, you can take the free assessment quiz to see whether a personalized program is a fit

Evidence for a class effect Several pieces of evidence suggest allodynia may be a GLP-1 receptor agonist class effect rather than specific to semaglutide

SUMMARY The glucagon-like peptide-1 receptor (GLP-1R) regulates insulin secretion, carbohydrate metabolism and appetite, and is an important target for treatment of type II diabetes and obesity